Skip to main content
Log in

Taban-Arshan: Immunocorrector in Atopic Bronchial Asthma

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Taban-Arshan extract decreased expression of T-lymphocyte activation markers, normalized T-cell-mediated immunity, and suppressed increased activity of natural killer receptors during culturing with lymphocytes of patients with atopic bronchial asthma. Taban-Arshan extract normalized activation processes in the B-cell immunity and stimulated expression of receptors of activation-induced apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. V. N. Lakusta, Lin Chzhi Shen, and N. V. Shinkarenko, Chzhen-Tszu Therapy of Asthma [in Russian], Kishinev (1995).

  2. G. V. Poryadin, A. N. Kazimirskii, Zh. M. Salmasi, et al., Klin, Patofiziol., No. 1, 5–11 (2002).

    Google Scholar 

  3. A. G. Chuchalin, Immunocorrection in Immunology [in Rus-sian], Moscow (1989).

  4. A. A. Yarilin, Fundamentals of Immunology [in Russian], Moscow (1999).

  5. A. Kumanogoh, C. Watanabe, I. Lee, et al., Immunity, 13, 621–631 (2000).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Semenova, L.Y., Salmasi, Z.M., Kazimirskii, A.N. et al. Taban-Arshan: Immunocorrector in Atopic Bronchial Asthma. Bulletin of Experimental Biology and Medicine 138, 65–66 (2004). https://doi.org/10.1023/B:BEBM.0000046941.60149.1e

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BEBM.0000046941.60149.1e

Navigation